|

Cladribine, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) regimen Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • H. Lee Moffitt Cancer Center and Research Institute1

Indications

  • Relapsed or Refractory Acute Myeloid Leukemia (AML)1
  • Cancer1

Tampa, Florida1 trial

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

Moffitt Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.